Assembly Biosciences, Inc. (ASMB)
28.42
-1.43
(-4.79%)
USD |
NASDAQ |
Apr 10, 16:00
28.40
-0.02
(-0.05%)
After-Hours: 20:00
Assembly Biosciences EPS Diluted (Quarterly) : 1.393 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -0.0716 |
| TELA Bio, Inc. | -0.1749 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 22.09M |
| Revenue (Quarterly) | 42.47M |
| Total Expenses (Quarterly) | 20.38M |
| Enterprise Value | 205.34M |
| Gross Profit Margin (Quarterly) | 99.92% |
| Profit Margin (Quarterly) | 52.01% |
| Earnings Yield | -6.47% |
| Normalized Earnings Yield | -6.469 |